Lunai Bioworks LNAI
NASDAQ LNAI
$1.30 -0.08 (-5.80%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lunai Bioworks (LNAI) Selling, General & Administrative (2011 - 2026)

Updated

Lunai Bioworks (LNAI) posted Selling, General & Administrative of $1.42 million for fiscal Q3 2026 (quarter ended Mar 31, 2026), down 66.4% from $4.22 million a year earlier and down 19.5% from the prior quarter.

Analysis

Lunai Bioworks (LNAI) Selling, General & Administrative (2011 - 2026) Analysis & Trends

For the trailing twelve months through Mar 31, 2026, Selling, General & Administrative at Lunai Bioworks was $9.6 million, down 49.2% year-over-year; for FY2025 (ended Jun 30, 2025), it came in at $17.88 million, down 27.2% from FY2024.

  • Annual Selling, General & Administrative shows a five-year compound annual growth rate of 20.2% (FY2020 to FY2025).
  • In prior fiscal years, Lunai Bioworks' Selling, General & Administrative was $24.56 million in FY2024 (+60.3%), $15.32 million in FY2023 (+6.9%), $14.33 million in FY2022 (+89.6%) and $7.56 million in FY2021 (+6.1%).
  • The fiscal Q3 2026 figure stands as the lowest quarterly Selling, General & Administrative since fiscal Q1 2019.
  • On a year-over-year basis, Selling, General & Administrative has declined in each of the last five quarters, with an average decline of 23.9% over the last eight quarters.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was fiscal Q1 2022, with growth of 148.5%; the weakest was fiscal Q3 2026, with a decline of 66.4%.
  • According to Business Quant data, Selling, General & Administrative for the three prior fiscal quarters was $1.77 million (Q2 2026), $2.41 million (Q1 2026) and $4 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Lunai Bioworks 4.31 Mn -440,776.51 20,942.00 1.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.42 Mn
Dec 31, 2025 1.77 Mn
Sep 30, 2025 2.41 Mn
Jun 30, 2025 4.00 Mn
Mar 31, 2025 4.22 Mn
Dec 31, 2024 4.35 Mn
Sep 30, 2024 5.30 Mn
Jun 30, 2024 5.00 Mn
Mar 31, 2024 7.65 Mn
Dec 31, 2023 3.62 Mn
Sep 30, 2023 8.29 Mn
Jun 30, 2023 2.95 Mn
Mar 31, 2023 3.80 Mn
Dec 31, 2022 4.01 Mn
Sep 30, 2022 4.56 Mn
Jun 30, 2022 3.16 Mn
Mar 31, 2022 2.79 Mn
Dec 31, 2021 3.96 Mn
Sep 30, 2021 4.42 Mn
Jun 30, 2021 2.01 Mn
API Access

Lunai Bioworks Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=LNAI&period=max&api_key=YOUR_API_KEY